Laboratories Inc Biovail serves as Executive at DEPOMED INC, where they oversee executive responsibilities. Since joining the company, Laboratories Inc Biovail has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 2, 2006 involved exercising options for 150,000 shares valued at $324.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 2, 2006 | DEPO | $324.0K | Exercise | 150,000 | $2.16 | Discretionary |
Laboratories Inc Biovail currently holds 4,242,032 shares of DEPOMED INC (DEPO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laboratories Inc Biovail has been a net neutral trader of DEPO stock. They have purchased $0 and sold $0 worth of shares.
Laboratories Inc Biovail's most recent insider trade was on May 2, 2006, when they sold 150,000 shares at $2.16 per share.
Get notified when new Form 4 filings are submitted